Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Biocept Inc

(NASDAQ: BIOC)
Add to Portfolio
-0.02 (-2.55%)
as of Nov 14, 2019

Profile
Ticker Symbol BIOC
Exchange NASDAQ
Contact Information
5810 Nancy Ridge Drive
San Diego, CA USA
P: 858-320-8200
CEO/President Michael W. Nall
Earnings at a Glance
Earnings 09/30/19
-0.25
06/30/19
-0.38
03/31/19
-0.61
12/31/18
-0.56
Price Earnings Ratio N/A
EPS Growth N/A
Most Recent Earnings ($) -0.38
Annual EPS ($) -4.84
Business Summary
Biocept Inc. is a commercial stage oncology diagnostics company. It has developed technology platforms for capture and analysis of circulating tumor cells and circulating tumor DNA utilizing a standard blood sample to provide physicians. The company offers OncoCEE-BR (TM) test for breast cancer. Biocept Inc. is headquartered in San Diego California.
Industry/Sector Information not available.